ABLIM1 and neoplasm: In contrast, in glioblastoma (GBM), ABLIM1 acts as a tumor suppressor, where its overexpression is associated with reduced tumor size and improved patient survival (28), implicating the diverse role of ABLIM1 in different cancer context.